Becton, Dickinson Offers Dividend And Growth Potential

Fri, 10/07/2011 - 02:49 EDT - Seeking Alpha

By Efficient Alpha:
By Carson Ko
Becton, Dickinson and Company (BDX) is a global medical technology manufacturer. BDX develops, manufactures and sells medical devices such as needles, syringes, prefillable drug delivery system, specimen and blood collection systems as well as analysis and research machinery for pharmaceutical and biotechnology companies.Becton, Dickinson and Company’s clients range from consumers, retailers, blood banks, clinical laboratories, hospitals, and Governmental and nonprofit public health agencies. BDX’s major competitors include Baxter (BAX), Covidien (COV), Boston Scientific (BSX), C.R. Bard (BCR), Hologic (HOLX), Gen-Probe (GPRO) and Retractable Tech (RVP). Below is a chart (click to enlarge) showing the trailing twelve months revenue comparison among BDX’s competitors. Although BDX is not the biggest fish in the pond, with 17% of the industry, it has a long history within the segment and has been able to maintain consistent revenue growth close to 10% annually.
Diversified Revenue Stream:
BDX’s operations are separated intoComplete Story »

Original article
Login or register to post comments

Becton Dickinson's Exceptional Growth Stands Out From The Pack
By Six Prime Investing: Becton, Dickinson & Co.
Becton, Dickinson and Company: The Ultimate Stock For Turbulent Times
By Shmulik Karpf: Becton, Dickinson and Company (BDX), a medical technology company, develops, manufactures and sells medical devices, instrument systems, and reagents worldwide.
Becton Dickinson & Co: Stock Research Analysis
By F.A.S.T. Graphs:This article is going to look at blue-chip dividend growth stock Becton Dickinson & Co (BDX) through the lens of FAST Graphs™, fundamentals analyzer software tool, which shows the company currently in value. The dividend growth investor might want to research this company further for a possible candidate for their portfolio.
Becton, Dickinson: Dividend Stock Analysis
By Dividend Growth Investor:Becton, Dickinson and Company (BDX), a medical technology company, develops, manufactures, and sells medical devices, instrument systems,
Becton Dickinson Dividend Stock Analysis
By Dividend Growth Investor:Becton, Dickinson and Company (BDX), a medical technology company, develops, manufactures and sells medical devices, instrument systems and reagents worldwide.
Becton Dickinson 2013 Dividend Stock Analysis
By Dividend Monk: Becton Dickinson is a global health company that focuses on durable medical supplies and medical devices.
Becton, Dickinson and Company: Dividend Stock Analysis
Dividend Growth Investor submits:Becton, Dickinson and Company (BDX), a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. This dividend champion has increased distributions for the past 38 consecutive years.
Becton Dickinson: Dividend Stock Analysis
Dividend Monk submits: Summary Becton Dickinson (BDX) is a global health company that focuses on durable medical supplies and medical devices. 5-Year Performance: Revenue Growth: 6% Income Growth: 13% Dividend Growth: 6.5% Current Dividend Yield: 2.08%
Becton Dickinson: A Dividend Star With a Lagging Price
Rising Dividend Investing submits: Click to enlarge
Becton, Dickinson and Company's Earnings Power Value
AsiaInvestor submits: Becton, Dickinson and Company (BDX) (“BD”) is a global medical technology company engaged principally in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

Main menu

Secondary menu

Becton, Dickinson Offers Dividend And Growth Potential

Related

Latest

User login

Our Blog

Markets Map

Follow Us

Secondary menu